Guangzhou Jingke Biotech Co., Ltd.
PrivateLast Round
Series C
Apr 19, 2021
Total Funding Raised
$45.59M
Company Overview
Guangzhou Jingke Biotech Co., Ltd. is a biotechnology company that specializes in the development and supply of NGS reagents, genetic testing solutions, and patient-derived organoid technology for personalized oncology and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Jingke Biotech Co., Ltd. Comparables
Compare Guangzhou Jingke Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Jingxin Industrial Development Co., Ltd. | 83% | |
| Hunan Xiangyi Laboratory Instrument Development Co., Ltd. | 78% | |
| Tiangen Biotech (Beijing) Co., Ltd. | 78% |
Guangzhou Jingke Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 19, 2021 | ||||
| Series B | Feb 18, 2019 | ||||
| Series A | Jun 1, 2017 | ||||
| Angel | Aug 27, 2016 |
Guangzhou Jingke Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sunland Fund | Series C |
| Oriental Fortune Capital | Angel, Series C |
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Angel |
| Yueyin Medical Fund | Series A |
| Zhejiang Jiuren Capital Management Co., Ltd. | Series B, Angel, Series C |
| Medfine Capital | Series A, Angel |
| Addor Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2021
Raised $31M led by Beijing Science Park Development and Sunland Fund.
- Feb 18, 2019
$15M round raised with participation from Zhejiang Jiuren Capital and China Growth Capital.
Guangzhou Jingke Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guangzhou Jingke Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Jingke Biotech Co., Ltd. a public or private company?
Guangzhou Jingke Biotech Co., Ltd. is a private company.
What is the current stock price of Guangzhou Jingke Biotech Co., Ltd.?
Guangzhou Jingke Biotech Co., Ltd. is a private company with no public stock price. Caplight tracks Guangzhou Jingke Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Guangzhou Jingke Biotech Co., Ltd. worth (valuation)?
Valuation information for Guangzhou Jingke Biotech Co., Ltd. is not publicly available.
Can I buy Guangzhou Jingke Biotech Co., Ltd. stock?
Guangzhou Jingke Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guangzhou Jingke Biotech Co., Ltd.'s last funding round?
Guangzhou Jingke Biotech Co., Ltd.'s most recent funding round was Series C on April 19, 2021.
Who are the main investors in Guangzhou Jingke Biotech Co., Ltd.?
Key investors in Guangzhou Jingke Biotech Co., Ltd. include Sunland Fund.
Will Guangzhou Jingke Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Jingke Biotech Co., Ltd..
How can I track Guangzhou Jingke Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou Jingke Biotech Co., Ltd.'s secondary market activity and sign up for updates.